Category | Insight journal – Dealtalk

Omega Pharma rumored to be sought after by big pharma companies

Posted on 01 September 2014

Belgium-based healthcare company Omega Pharma NV is allegedly attracting numerous bids from businesses across the big pharma companies, according to Bloomberg Businessweek. Perrigo and Boehringer Ingelheim GmbH are rumored to be interested in acquiring the company. 

Tags: , , , , ,

AstraZeneca and Pfizer in the news for another possible m&a bid

Posted on 01 September 2014

AstraZeneca stock rose two percent to £45.67 pounds yesterday after the Swedish newspaper Dagens Industry suggested another possible Pfizer m&a  bid. AstraZeneca stocks have risen 9.5% in the last week, following a stream of good news regarding its pipeline and takeover bids by Pfizer.

Tags: , , ,

M&A rumors for buyout of Achillion Pharmaceuticals by big pharma

Posted on 28 August 2014

UBS analyst Andrew Peters suggested that a recent takeover big in the biotech space of California-based InterMune, Inc.  by Roche was the harbinger of more M&A rumors to come.

Tags: , , ,

Roche drops business merger rumors with Chugai Pharmaceutical

Posted on 27 August 2014

Roche had business merger rumors to buy Tokyo-based Chugai Pharmaceutical Co., Ltd. appear to be tabled for now. Sources in Roche indicated the company was focused on its $8.3 billion acquisition of California-based InterMune Inc.

Tags: , , ,

Is Pfizer’s next acquisition target, Activas?

Posted on 22 August 2014

Bloomberg reports, Pfizer is looking at Actavis, the generics maker with a new home address in Ireland, among other targets.

Tags: , ,

Mylan bids on old drugs of GSK

Posted on 22 August 2014

Several companies, including Mylan , have submitted a second round of bidding for a portfolio of older GlaxoSmithKline drugs.  

Tags: , , , , ,

Cubist Pharma, the next acquisition target for big pharmaceuticals

Posted on 19 August 2014

The timing may be right for a takeover of Cubist Pharmaceuticals.

Tags: , ,

Roche to buy 40% stake in Chugai Pharma

Posted on 18 August 2014

Roche Holding is in talks to buy the almost 40 percent of Chugai Pharmaceutical that it doesn’t already own to gain full control of its Japanese partner for oncology and arthritis drugs, according to people familiar with the matter.

Tags: ,

InterMune looking for oppurtunities for buyout

Posted on 15 August 2014

Multiple sources are reporting that biotechnology company, InterMune, Inc. (ITMN), is officially preparing for a buyout.

Tags: ,

Life Science M&A Deal Trends in Q2, 2014

Posted on 14 August 2014

By Steve Poile                                     With 110 deals announced, the second quarter continued on from the strong start for life science M&A during 2014.

Tags: ,

cpbannerad300x150new2gif
e56300x150animgif
beu14banner300x150jpg
RSS Feed Linked In Twitter

Latest Tweets

cabannerad300x150new4gif
strategicalliances082114jpg
ddp-banner-for-current-partgif